By Gwendolyn Wu | October 9, 2026 In a significant signal of renewed investor appetite for immunology-focused...
Chemotherapy and Targeted Therapy
The landscape of preclinical drug development is undergoing a seismic shift. For decades, the standard procedure for...
By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...
By Jonathan Gardner Published October 8, 2026 In a move designed to fortify its position as a...
The field of digital pathology, once a niche sub-specialty, has undergone a radical transformation. Accelerated by the...
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company born from the pioneering...
In the high-stakes world of pharmaceutical development, the path from a lead compound to a human clinical...
In a sobering development for the biotechnology sector, Caribou Biosciences—a CRISPR-focused firm co-founded by Nobel laureate Jennifer...
In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...
In a stark reminder of the volatility inherent in the biotechnology sector, Caribou Biosciences, a CRISPR-focused pioneer...
